What is the global market size of Clinical Trial Packaging Market?

Clinical Trial Packaging Market size was valued at USD 1079.09 million in 2019 and is poised to grow from USD 1169.76 million in 2023 to USD 2199.06 million by 2031, growing at a CAGR of 8.21% in the forecast period (2024-2031).

Clinical Trial Packaging Market Worldwide

Clinical Trial Packaging Market Regional Insights

North America dominated the Global Clinical Trial Packaging Market share and accounted for approximately 50% global revenue share in 2021. It is expected to continue its dominance during the forecast period. The pharmaceutical industry's success in North America is largely attributable to the region's abundance of clinical trials organisations and research labs. The pharmaceutical sector in North America is expected to develop at a rapid rate throughout the projected period due to a rise in R&D efforts. During the forecast period, the presence of stringent FDA rules for the packaging of goods and medications used in clinical trials is anticipated to drive regional clinical trials packaging market growth.

Asia Pacific region holds a substantial market share and is anticipated to grow at the fastest growth rate during the forecast period. The main drivers of the growth of the market throughout the projected period are an increase in R&D spending and a booming pharmaceutical sector in emerging nations like China, India, and Japan. Due to expanding government programmes, expanding contract manufacturing operations, and a rapidly ageing population, China topped the Asia Pacific market in 2021 and will continue to hold the top spot in the years to come.

FAQs

Clinical Trial Packaging Market size was valued at USD 1169.76 Million in 2023 and is poised to grow from USD 1265.8 Million in 2024 to USD 2379.6 Million by 2032, growing at a CAGR of 8.21% during the forecast period (2025-2032).

Global Clinical Trial Packaging Market is highly competitive and fragmented due to few major players. To increase their market share, the major companies in the international market are implementing a variety of business tactics, including mergers and acquisitions, expansions, and investments. Major players include Almac Group, Piramal Pharma Solutions, Clinical Supplies Management Holdings, Inc., Fisher Clinical Services, Inc. and others. These prominent players are focusing on R&D and new product development to stabilize their market share. 'Westrock Company ', 'Bilcare Limited ', 'Sharp Packaging Services ', 'Fisher Clinical Services ', 'Almac Group ', 'Schreiner MediPharm ', 'Mawdsleys Berlinger ', 'Stora Enso Oyj ', 'Thermo Fisher Scientific Inc. ', 'Wuxi Griffin Pharmaceutical Co., Ltd. ', 'WuXi AppTec ', 'Reed-Lane, Inc. ', 'Aphena Pharma Solutions ', 'Catalent, Inc. ', 'Berry Global, Inc. ', 'Nupharm Group ', 'Carton Service, Inc. '

Due to recent changes made to the methods utilised in pharmaceutical industry's research and development as well as the growing need for cutting-edge products and cures, it is projected that the global market will grow. The emergence of issues related to the use of plastic is also driving the demand for glass bottles. It is anticipated that the growth of the global clinical trial packaging market would be significantly impacted during the anticipated period by rising prevalence of infectious disorders

Aseptic blow-fill-seal (BFS) technology is a method for forming plastic containers, filling them with sterile, filtered product, and sealing them in a continuous sequence of steps inside a sterile, controlled environment on a single machine. The blow-fill-seal method is a reliable, cutting-edge aseptic processing technique that has gained the respect of regulatory bodies throughout the world for the inherent advantages it offers over traditional aseptic manufacturing. The versatility in packaging design, cheap operating costs, and high level of sterility assurance that come with blow-fill-seal systems is unmatched. The devices demand a minimal amount of operational workers and a small amount of space. Due to the growing emphasis on biologics, proteins, and other complicated solutions in recent years, blow-fill-seal technology has attracted a lot of market attention. These crucial goods frequently cannot endure prolonged contact to high temperatures without the active ingredients degrading.